A 3D customized medical dressing for unidirectionally discharging permeate and a preparation method thereof

Through differential capillary effect and 3D electrospinning printing technology, composite dressings that can discharge permeate fluid in one direction are prepared, solving the problems of permeate fluid discharge and personalized customization in the prior art, and achieving efficient wound care and uniform dressing specifications.

CN117244097BActive Publication Date: 2024-11-15GUANGDONG PHARMA UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202311455123.X
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-11-02
Publication Date
2024-11-15
Estimated Expiration
2043-11-02

AI Technical Summary

Technical Problem

It is difficult to achieve one-way discharge of permeate and personalized customization for existing medical dressings, and electrospinning technology has problems of uneven electrostatic power and uneven fiber morphology, which cannot meet the efficient care needs of wound wounds with varying depths and concave convexity.

Method used

Using differential capillary effect-induced composite affinity dressing, combined with 3D electrospinning printing technology, the printing ink of sodium alginate and gelatin is printed and electrospinned on a 3D printer to form a hydrophobic layer and a hydrophilic layer to achieve one-way discharge and permeability. The function of liquid is customized through computer-aided design and near-field electrospinning technology.

Benefits of technology

It realizes efficient directional discharge and purification of wound exudate, provides personalized care effects, avoids the problems of electrostatic power in electrospinning technology and uneven fiber morphology, and ensures uniform specifications and safety of dressings.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN117244097B_ABST
    Figure CN117244097B_ABST
Patent Text Reader

Abstract

The present invention belongs to the field of medical dressings, and specifically relates to a 3D customized medical dressing for unidirectional discharge of permeate and a preparation method thereof. The preparation method comprises: (1) dissolving sodium alginate and gelatin in water, stirring, and obtaining printing ink; (2) using computer-aided design software to draw and model the structure of the medical dressing, pouring the printing ink into a 3D printer material tube for printing, and obtaining a sodium alginate hydrogel; (3) vacuum freeze-drying the sodium alginate hydrogel, soaking it in a calcium chloride solution for cross-linking, and post-processing to obtain a sodium alginate fiber membrane; (4) heating and melting polycaprolactone particles, injecting them into a metal syringe, and spinning them on the surface of the sodium alginate fiber membrane using a 3D electrospinning printer. The present invention accurately customizes the shape and size of the wound dressing, improves the wound repair effect, and realizes the customized design of the whole process from treatment to repair and the precise treatment of patients.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the field of medical dressings, and in particular relates to a 3D customized medical dressing for unidirectionally discharging permeate and a preparation method thereof. Background Art

[0002] Wounds are a common clinical condition for millions of patients worldwide. Their main manifestations are wounds of varying depths and shapes. The depth of wound lesions can reach the dermis or below the dermis. The ulcers vary in size and can invade the periphery or deep into the body. The surface is covered with various exudates.

[0003] Wounds are generally caused by damage and rupture due to external physical injury factors such as external force, heat, and electric current. In addition, wounds may also be complications caused by diseases caused by disorders in the body's physiological functions. Such wounds are mostly located in areas with dense connective tissue and relatively poor blood supply, such as the tibia, ankle, and foot, which are uneven areas. Most wound dressings are only used for trauma on flat or static wounds, while wounds with varying depths and uneven surfaces have more stringent requirements for dressings and require more personalized and precise treatment. The purpose of wound dressings is to establish and maintain optimal conditions for repairing damaged tissue. However, how to protect the wound and promote healing while ensuring the patient's normal activities has always been a difficult problem in the field of wound care. To solve this problem, multifunctional and multi-material medical dressings and preparation technologies have emerged.

[0004] Traditional medical dressings are mostly prepared using relatively cumbersome procedures such as hydroentanglement, knitting, and freeze-drying. With the advancement of medical technology, the preparation technology of medical dressings is also being updated. Among the many new dressing preparation technologies, electrospinning has become the most popular technology for new dressings in recent years because it can create drug-loaded medical dressings with appropriate porosity. Although ordinary electrospinning medical dressings have great potential for future development, in addition to being limited by the expensive equipment costs, researchers have found that the electrostatic force required to form nanofibers during ordinary electrospinning is large, and the distance from the receiving plate to the needle mouth is long and uneven, resulting in different electrostatic forces and irregular distribution in the substrate. The fiber morphology is also uneven, which can easily lead to uneven dressing thickness and the inability to standardize the specifications of medical dressings. Subsequent processing such as shearing, splitting, or merging is required, making large-scale preparation difficult.

[0005] Chinese invention patent application CN113858610A discloses a medical fibrous surface dressing and its preparation method and application, comprising the following steps: (1) mixing polylactic acid, a first solvent, and a second solvent to obtain a mixture; (2) stirring the mixture to completely dissolve the polylactic acid to obtain a casting solution; (3) placing the casting solution as printing ink in a printing barrel of a 3D printer; (4) precooling the 3D printing platform; (5) setting the printing parameters of the 3D printer and printing using a printing path planning program provided in the 3D printer to obtain a fibrous surface dressing preform; and (6) freezing and washing the fibrous surface dressing preform to obtain a medical fibrous surface dressing. However, the dressing prepared by this method cannot achieve the purpose of unidirectionally discharging the permeate.

[0006] Chinese invention patent application CN111557790A discloses an antibacterial and disinfecting nanofiber medical dressing, comprising a laminated composite base layer, a core layer, an adhesive layer, and a glossy release layer. The core layer comprises a laminated composite first, second, and third dressing layers. The first auxiliary material layer is a chitosan fiber membrane layer electrospun from chitosan and glycerol in a weight ratio of 10:1. The second dressing layer is a hyaluronic acid fiber membrane layer composed of hyaluronic acid fibers produced by electrospinning. The third dressing layer is an alginate dressing layer. This medical dressing has hemostatic and antibacterial properties, moisturizing properties, and promotes wound healing. However, the preparation process is complex and does not achieve unidirectional permeate discharge.

[0007] Due to the complex biological mechanisms of wound healing, the composition of exudate varies during the tissue repair process. The assessment of wound tissue fluid exudate is key to scientific wound management. Clinical medical staff often rely on subjective judgment to assess wound tissue fluid exudate, resulting in large errors. For example, high-exudate wounds are not suitable for low-exudate dressings. Using high-exudate dressings on low-exudate wounds can cause the dressing to adhere to the wound, worsening the wound condition. Therefore, wound repair places extremely high demands on dressings. On the one hand, they need to efficiently drain wound exudate to provide a suitable healing environment for wound healing. On the other hand, they also require timely antibacterial care of the wound to ensure smooth subsequent healing stages.

[0008] Therefore, developing a multifunctional dressing with efficient one-way drainage and 3D personalized customization has become a technical problem that urgently needs to be solved in the field of wound dressing. Summary of the Invention

[0009] In response to the shortcomings of the above-mentioned prior art, the present invention provides a 3D customized medical dressing for unidirectional exudate discharge and a preparation method thereof. The internal pore size of the wound dressing is customized according to the dressing density requirements of different wound exudates. The differential capillary effect is used to induce the composite hydrophilic dressing to achieve a self-pumping effect, promoting the directional discharge of wound exudate, so that the dressing has the functions of purifying the wound environment and directional exudate discharge. The simultaneous use of 3D electrospinning printing technology not only solves the problem of personalized customization, but also, combined with near-field electrospinning technology, solves the uneven electrostatic force and irregular spinning caused by conventional electrospinning technology.

[0010] To achieve the above object, the technical solution adopted by the present invention is as follows:

[0011] A method for preparing a 3D customized medical dressing capable of unidirectionally discharging permeate comprises the following steps:

[0012] (1) Dissolving sodium alginate and gelatin in water and stirring to obtain printing ink;

[0013] (2) Using computer-aided design software to draw and model the structure of the medical dressing, pouring printing ink into the material tube of an extrusion-type 3D printer for printing to obtain a sodium alginate hydrogel;

[0014] (3) vacuum freeze-drying the sodium alginate hydrogel, immersing it in a calcium chloride solution for cross-linking, and post-processing to obtain a sodium alginate fiber membrane;

[0015] (4) The polycaprolactone particles are heated and melted, injected into a metal syringe, and then spun on the surface of a sodium alginate fiber membrane using a 3D electrospinning printer to obtain a 3D customized medical dressing that unidirectionally discharges the permeate.

[0016] Preferably, the molecular weight of the sodium alginate in step (1) is 20,000-50,000, preferably 30,000, and the molecular weight of the gelatin is 100,000-300,000, preferably 200,000; the mass ratio of sodium alginate to gelatin is 1-7:7-1.

[0017] Preferably, the stirring temperature in step (1) is 40-60° C., the stirring speed is 100-1000 r / min, and the stirring time is 4-12 h; and after stirring, the method further includes a step of centrifugation to eliminate bubbles in the solution.

[0018] Preferably, the computer-aided design software in step (2) includes CAD software; the temperature of the printing ink is 40-60°C; the printing parameter settings include: printing pressure of 0.06MPa-0.1MPa, printing speed of 8mm / s-16mm / s, printing spacing of 50μm-1000μm, platform temperature of 20-30°C, and needle diameter of 0.26mm-0.41mm.

[0019] Preferably, the mass concentration of the calcium chloride solution in step (3) is 2%-5%, and the cross-linking time is 25-35 minutes; the post-treatment comprises: soaking the cross-linked sodium alginate hydrogel in deionized water for 25-35 minutes, removing the residual calcium chloride solution, and then vacuum freeze-drying for 36-48 hours.

[0020] Preferably, the molecular weight of the polycaprolactone in step (4) is 200,000-300,000, preferably 300,000, and the heating temperature is 75-110°C.

[0021] Preferably, the parameter settings of the 3D electrospinning printer in step (4) include: printing temperature of 75°C-110°C, printing pressure of 5kPa-10kPa, printing speed of 10mm / s-100mm / s, acceleration of 100mm / s 2 -300mm / s 2 , the printing voltage is 1.4kV-2.8kV, the printing spacing is 10μm-100μm, the platform temperature is 20-30℃, and the needle diameter is 0.30mm-0.80mm.

[0022] The present invention also relates to a 3D customized medical dressing prepared by the above-mentioned preparation method, wherein the 3D customized medical dressing comprises a hydrophobic layer (1) and a hydrophilic layer (2).

[0023] Preferably, the hydrophobic layer (1) has a thickness of 1 mm to 10 mm and a contact angle of >100°; the hydrophilic layer (2) has a thickness of 1 mm to 100 mm and a contact angle of <60°.

[0024] Preferably, the pore size of the hydrophobic layer (1) is 10 μm-200 μm, and the pore size of the hydrophilic layer (2) is 1 μm-20 μm; the hydrophobic layer (1) is a polycaprolactone fiber membrane, and the hydrophilic layer (2) is a sodium alginate fiber membrane.

[0025] Compared with the prior art, the present invention has the following beneficial effects:

[0026] (1) The present invention utilizes wettability gradient and differential capillary effect to induce composite dressing to achieve unidirectional fluid seepage, thereby purifying the wound environment to prevent bacterial growth and infection in the wound.

[0027] (2) The present invention is based on 3D printing technology and has the advantage of personalized customization. The shape and size of the dressing can be customized on a macro level, and the internal pore size of the dressing can be customized on a micro level, so that the wound can receive multi-level and precise care and treatment.

[0028] (3) The present invention combines 3D printing with near-field spinning, and uses electric potential to cross-link the two layers of dressing into a composite dressing, avoiding the safety hazard of residual chemical reagents in the chemical cross-linking method, and the preparation process is safe.

[0029] (4) Compared with conventional electrospinning technology, the 3D near-field spinning used in the present invention has the advantages of printing uniform fiber morphology and thickness, while also avoiding the safety issue of organic reagent volatilization during the spinning process.

[0030] (5) The fiber carrier prepared by the technology described in the present invention is suitable for a variety of therapeutic drugs. It can be added to the printing solution and then blended and dispersed into the fiber membrane, so that it has antibacterial, anti-inflammatory, hemostatic and other effects. BRIEF DESCRIPTION OF THE DRAWINGS

[0031] Figure 1 Schematic diagram of the structure of the 3D customized medical dressing prepared in Example 1, 1-hydrophobic layer, 2-hydrophilic layer;

[0032] Figure 2 This is a polarizing microscope image of the interior of the medical dressing prepared by 3D electrospinning in Example 1;

[0033] Figure 3 Polarized light microscope image of the interior of the medical dressing prepared by conventional electrospinning in Comparative Example 1;

[0034] Figure 4 3D customized medical dressing prepared in Example 2 is shown in front view, top view and side view;

[0035] Figure 5 This is a test diagram of the forward moisture conduction performance of the 3D customized medical dressing prepared in Example 1;

[0036] Figure 6 This is a test diagram of the reverse moisture conduction performance of the 3D customized medical dressing prepared in Example 1. DETAILED DESCRIPTION

[0037] The technical solutions in the embodiments of the present invention are further clearly described. The described embodiments are only a part of the present invention and are used to explain the present invention, but not to limit the present invention. Therefore, other embodiments obtained by other technicians in this field without creative work all fall within the scope of protection of the present invention.

[0038] Sodium alginate, purchased from Shanghai Aladdin Biochemical Technology Co., Ltd., AR, molecular weight 30,000;

[0039] Gelatin, purchased from Shanghai Aladdin Biochemical Technology Co., Ltd., AR, molecular weight 200,000;

[0040] Polycaprolactone particles were purchased from Shanghai MacLean Biochemical Technology Co., Ltd. with a molecular weight of 300,000.

[0041] The following reagents not otherwise specified are conventional reagents and are commercially available.

[0042] Example 1

[0043] A schematic diagram of the structure of a 3D customized medical dressing with one-way drainage of permeate is shown below. Figure 1 As shown, 1-hydrophobic layer, 2-hydrophilic layer; its preparation method is:

[0044] (1) 5.0 g of sodium alginate and 5.0 g of gelatin were dissolved in water, stirred at 50°C, 500 rpm, stirred for 8 h, and centrifuged for 5 min to eliminate bubbles in the solution, thereby preparing a printing ink;

[0045] (2) Using computer-aided design (CAD) software to draw and model the structure of the medical dressing, the size of the medical dressing model was preset to a square grid structure of 30 mm * 30 mm * 2 mm;

[0046] (3) The designed model was exported as an STL file and imported into the Ultimaker Cura software to open it. In the software, the basic printing parameters were set as follows: printing pressure of 0.08 MPa, printing speed of 12 mm / s, printing spacing of 50 μm, platform temperature of 25 °C, internal structure of 0° and 90° staggered arrangement, needle diameter of 0.26 mm, layer thickness of 0.3 mm, and the 3D printer was started. The sodium alginate hydrogel was printed using printing ink.

[0047] (4) The printed sodium alginate hydrogel was placed in a freezer at -20°C for 12 hours, vacuum freeze-dried for 36 hours, and then immersed in a 3% calcium chloride solution for cross-linking for 30 minutes. After cross-linking, it was immersed in deionized water for 30 minutes to remove the residual calcium chloride solution, and then vacuum freeze-dried for 48 hours to obtain a sodium alginate fiber membrane;

[0048] (5) After the polycaprolactone particles were melted at 95°C, they were injected into a metal syringe. The basic printing parameters were set on the Ultimaker Cura software connected to the 3D printer: printing temperature of 95°C, printing pressure of 6 kPa, printing speed of 30 mm / s, and acceleration of 100 mm / s. 2 , the printing voltage is 1.8kV, the printing pitch is 100μm, the platform temperature is 25℃, and the needle diameter is 0.35mm;

[0049] (6) The sodium alginate fiber membrane prepared in step (4) is clamped on the conductive glass. The generated dedicated folder is sent to the 3D electrospinning printer according to the model designed in step (2). 3D electrospinning is performed on the surface of the sodium alginate fiber membrane. The electrospinning time is 40 minutes, and the conductive glass printing range is 25 cm. 2 , and finally a double-layer composite one-way exudate discharge medical dressing is obtained.

[0050] The polarizing microscope image of the inside of the medical dressing in this embodiment is as follows: Figure 2 shown.

[0051] Example 2

[0052] A method for preparing a 3D customized medical dressing with one-way permeate discharge:

[0053] (1) 1.0 g of sodium alginate and 7.0 g of gelatin were dissolved in water, stirred at 40°C, 100 rpm, stirred for 12 h, and centrifuged for 10 min to eliminate bubbles in the solution, thereby preparing a printing ink;

[0054] (2) Using computer-aided design (CAD) software, the structure of the medical dressing was modeled and the size of the medical dressing model was preset to an arch-shaped arc structure of 20 mm*10 mm*15 mm.

[0055] (3) The designed model was exported as an STL file and imported into the Ultimaker Cura software to open it. In the software, the basic printing parameters were set as follows: printing pressure of 0.1 MPa, printing speed of 10 mm / s, printing spacing of 50 μm, platform temperature of 25 °C, internal structure of 0° and 90° staggered arrangement, needle diameter of 0.26 mm, layer thickness of 0.3 mm, and the 3D printer was started. The sodium alginate hydrogel was printed using printing ink.

[0056] (4) The printed sodium alginate hydrogel was placed in a freezer at -20°C for 12 hours, vacuum freeze-dried for 36 hours, and then immersed in a 5% calcium chloride solution for cross-linking for 25 minutes. After cross-linking, it was immersed in deionized water for 25 minutes to remove the residual calcium chloride solution, and then vacuum freeze-dried for 48 hours to obtain a sodium alginate fiber membrane;

[0057] (5) After the polycaprolactone particles were melted at 90°C, they were injected into a metal syringe. The basic printing parameters were set on the Ultimaker Cura software connected to the 3D printer: printing temperature of 90°C, printing pressure of 6 kPa, printing speed of 30 mm / s, and acceleration of 100 mm / s. 2 , the printing voltage is 1.8kV, the printing pitch is 100μm, the platform temperature is 25℃, and the needle diameter is 0.35mm;

[0058] (6) The sodium alginate fiber membrane prepared in step (4) is clamped on the conductive glass. The generated dedicated folder is sent to the 3D electrospinning printer according to the model designed in step (2). 3D electrospinning is performed on the surface of the sodium alginate fiber membrane. The electrospinning time is 60 minutes, and the conductive glass printing range is 25 cm. 2 Finally, a double-layer composite one-way exudate discharge medical dressing is obtained, such as Figure 4 shown.

[0059] Example 3

[0060] A method for preparing a 3D customized medical dressing with one-way permeate discharge:

[0061] (1) 7.0 g of sodium alginate and 1.0 g of gelatin were dissolved in water, stirred at 60°C, 1000 rpm, stirred for 4 h, and centrifuged for 8 min to eliminate bubbles in the solution, thereby preparing a printing ink;

[0062] (2) Using computer-aided design (CAD) software to draw and model the structure of the medical dressing, the size of the medical dressing model was preset to a square grid structure of 30 mm * 30 mm * 2 mm;

[0063] (3) The designed model was exported as an STL file and imported into the Ultimaker Cura software to open it. In the software, the basic printing parameters were set as follows: printing pressure of 0.06 MPa, printing speed of 16 mm / s, printing spacing of 50 μm, platform temperature of 25 °C, internal structure of 0° and 90° staggered arrangement, needle diameter of 0.26 mm, layer thickness of 0.3 mm, and the 3D printer was started. The sodium alginate hydrogel was printed using printing ink.

[0064] (4) The printed sodium alginate hydrogel was placed in a freezer at -20°C for 12 hours, vacuum freeze-dried for 36 hours, and then immersed in a 3% calcium chloride solution for cross-linking for 35 minutes. After cross-linking, it was immersed in deionized water for 35 minutes to remove the residual calcium chloride solution, and then vacuum freeze-dried for 48 hours to obtain a sodium alginate fiber membrane;

[0065] (5) After the polycaprolactone particles were melted at 100°C, they were injected into a metal syringe. The basic printing parameters were set on the Ultimaker Cura software connected to the 3D printer: printing temperature of 100°C, printing pressure of 6 kPa, printing speed of 30 mm / s, and acceleration of 100 mm / s. 2 , the printing voltage is 1.8kV, the printing pitch is 100μm, the platform temperature is 25℃, and the needle diameter is 0.35mm;

[0066] (6) The sodium alginate fiber membrane prepared in step (4) is clamped on the conductive glass. The generated dedicated folder is sent to the 3D electrospinning printer according to the model designed in step (2). 3D electrospinning is performed on the surface of the sodium alginate fiber membrane. The electrospinning time is 40 minutes, and the conductive glass printing range is 25 cm. 2 , and finally a double-layer composite one-way exudate discharge medical dressing is obtained.

[0067] Comparative Example 1

[0068] A 3D customized medical dressing capable of unidirectionally discharging permeate, the preparation method of which is as follows:

[0069] (1) 5.0 g of sodium alginate was dissolved in water, stirred at 60°C, 1000 rpm, stirred for 4 h, and centrifuged for 8 min to eliminate bubbles in the solution, thereby preparing a printing ink;

[0070] (2) Using computer-aided design (CAD) software to draw and model the structure of the medical dressing, the size of the medical dressing model was preset to a square grid structure of 30 mm * 30 mm * 2 mm;

[0071] (3) The designed model was exported as an STL file and imported into the Ultimaker Cura software to open it. In the software, the basic printing parameters were set as follows: printing pressure of 0.06 MPa, printing speed of 16 mm / s, printing spacing of 50 μm, platform temperature of 25 °C, internal structure of 0° and 90° staggered arrangement, needle diameter of 0.26 mm, layer thickness of 0.3 mm, and the 3D printer was started. The sodium alginate hydrogel was printed using printing ink.

[0072] (4) The printed sodium alginate hydrogel was placed in a freezer at -20°C for 12 hours, vacuum freeze-dried for 36 hours, and then immersed in a 3% calcium chloride solution for cross-linking for 35 minutes. After cross-linking, it was immersed in deionized water for 35 minutes to remove the residual calcium chloride solution, and then vacuum freeze-dried for 48 hours to obtain a sodium alginate fiber membrane;

[0073] (5) After the polycaprolactone particles were melted at 100°C, they were injected into a metal syringe. The basic printing parameters were set on the Ultimaker Cura software connected to the 3D printer: printing temperature of 100°C, printing pressure of 6 kPa, printing speed of 30 mm / s, and acceleration of 100 mm / s. 2 , the printing voltage is 1.8kV, the printing pitch is 100μm, the platform temperature is 25℃, and the needle diameter is 0.35mm;

[0074] (6) The sodium alginate fiber membrane prepared in step (4) is clamped on the conductive glass. The generated dedicated folder is sent to the 3D electrospinning printer according to the model designed in step (2). 3D electrospinning is performed on the surface of the sodium alginate fiber membrane. The electrospinning time is 40 minutes, and the conductive glass printing range is 25 cm. 2 , and finally a double-layer composite one-way exudate discharge medical dressing is obtained.

[0075] The sodium alginate fiber membrane prepared in this comparative example has poor mechanical properties and will crack and shrink after being freeze-dried.

[0076] Comparative Example 2

[0077] A medical dressing prepared by ordinary electrospinning, the preparation method is as follows:

[0078] (1) Dissolve 5 g of gelatin, 1 g of sodium alginate, and 10 g of polyethylene oxide powder in deionized water and stir at 200 rpm for 10 h to obtain a uniform hydrophilic spinning solution.

[0079] (2) Another 10 g of polycaprolactone was dissolved in N,N-dimethylformamide, sealed and magnetically stirred at 600 rpm for 12 h to obtain a uniform hydrophobic polycaprolactone spinning solution.

[0080] (3) Add the spinning solution prepared in step (1) to the electrospinning syringe, adjust the parameters and perform spinning for 2-3 hours. The spinning process parameters are: voltage 20 kV, spinning rate 0.1 ml / h, receiving distance 16 cm, and needle 22G flat-head needle;

[0081] (4) Soaking the spun membrane prepared in step (3) in a 3% calcium chloride solution for crosslinking for 35 minutes, soaking it in deionized water for 35 minutes after crosslinking, removing the residual calcium chloride solution, and then vacuum freeze-drying it for 48 hours to finally obtain a hydrophilic fiber membrane;

[0082] (5) The spinning solution prepared in step (2) was added to an electrospinning syringe, and the fiber membrane prepared in step (4) was clamped on a conductive glass to perform electrospinning on the sodium alginate fiber membrane. The spinning process parameters were: voltage 16 kV, spinning rate 0.1 ml / h, receiving distance 15 cm, and needle 22G flat-head needle;

[0083] (6) The prepared medical dressing needs to be ventilated in a fume hood for 12 hours to remove the organic reagents in the spinning solution, and finally cut into medical dressings with a size of 30mm*30mm.

[0084] The polarizing microscope picture of the interior of the Chinese medicine dressing in this comparative example is as follows: Figure 3 shown.

[0085] Comparative Example 3

[0086] A commercially available medical dressing was purchased from Guangzhou Panyu Wanfu Hygiene Products Co., Ltd.

[0087] Effect test Test example 1 Contact angle measurement

[0088] Contact angle measurement method:

[0089] The prepared dressings were placed in a desiccator and dried for 24 hours. Contact angles were then measured using a contact angle meter. 3 μL of water was dropped onto the surface of each sample, and the contact angle was recorded. A contact angle greater than 90° indicates a hydrophobic material, while a contact angle less than 90° indicates a hydrophilic material. The results are shown in Table 1. Comparative Example 3 was a commercially available medical dressing without a hydrophobic layer.

[0090] Table 1 Contact angle test results of the dressings obtained in Examples 1-3 and Comparative Examples 1-3

[0091]

[0092] Test Example 2 Liquid Absorption and Air Permeability Test

[0093] 1. Determination of liquid absorption performance:

[0094] Prepare a test solution simulating the ion content of human serum or wound exudate: Dissolve 8.298g of sodium chloride and 0.368g of calcium chloride dihydrate in a volumetric flask with deionized water and dilute to 1L. Dry the sample in a desiccator, weigh it, and record it as the initial mass M0. Then place it in a culture dish, add the test solution preheated to 37°C, move it into a drying oven, and keep it at 37°C for 30 minutes. Use tweezers to hold the sample at one corner or one end and hang it for 30 seconds. Weigh it and record it as the absorbed mass M. t The above steps were repeated three times in parallel. The liquid absorption performance test results of the dressings obtained in Examples 1-3 and Comparative Examples 1-3, as well as the theoretical values ​​according to national industry standards, are shown in Table 3.

[0095] Table 3 Test results of liquid absorption performance of the dressings obtained in Examples 1-3 and Comparative Examples 1-3

[0096]

[0097] 2. Air permeability test method:

[0098] First, pour distilled water into the glass bottle, cover the sample with known initial mass M0 and fix it on the cup mouth, then put it into the constant temperature shaking box, take it out and weigh M after 24 hours. t , calculate the air permeability of medical dressings. The following is the formula for calculating moisture permeability:

[0099] WVRT=△M / St

[0100] Where WVRT is the moisture permeability, g / m 2 / d; △M is the mass difference of the sample before and after the experiment, g; S is the effective area of ​​the test, m 2 ; t is the test time, d.

[0101] The air permeability test results and the human skin wound healing standards are shown in Table 4.

[0102] Table 4 shows the air permeability test results and the human skin wound healing standard of the embodiment.

[0103]

[0104] Test Example 3: One-way moisture removal test of medical dressing

[0105] Test method: Take the one-way moisture-wicking dressing prepared in Example 1 and fix it on a rack. Then use a disposable dropper to absorb red ink and continuously add red ink to the hydrophobic and hydrophilic surfaces of the composite dressing. During the test, observe the liquid penetration and take photos with a camera. Figure 5 and Figure 6 .

[0106] The above measurement method was repeated on the commercially available medical dressing of Comparative Example 3. It was found that the commercially available medical dressing had no one-way moisture removal effect. When ink dropped on the commercially available medical dressing, it was immediately absorbed and had no one-way penetration effect on the medical dressing.

[0107] The above detailed description is a specific description of one feasible embodiment of the present invention. This embodiment is not intended to limit the patent scope of the present invention. Any equivalent implementation or modification that does not depart from the present invention should be included in the scope of the technical solution of the present invention.

Claims

1. A method for preparing a 3D customized medical dressing for unidirectionally discharging permeate, characterized in that: The following steps are involved: (1) dissolving sodium alginate and gelatin in water and stirring to obtain printing ink; (2) using computer-aided design software to draw and model the structure of the medical dressing, pouring printing ink into the material tube of an extrusion 3D printer for printing, and obtaining a sodium alginate hydrogel; (3) freeze-drying the sodium alginate hydrogel in vacuum, and immersing it in a calcium chloride solution for cross-linking to obtain a sodium alginate fiber membrane; (4) heating and melting the polycaprolactone particles, injecting them into a metal syringe, and spinning them on the surface of the sodium alginate fiber membrane using a 3D electrospinning printer to obtain a 3D customized medical dressing that unidirectionally discharges the permeate; In step (1), the molecular weight of sodium alginate is 20000-50000, and the molecular weight of gelatin is 100000-300000; the mass ratio of sodium alginate to gelatin is 1-7:7-1.

2. The preparation method according to claim 1, characterized in that: The stirring temperature in step (1) is 40-60° C., the stirring speed is 100-1000 r / min, and the stirring time is 4-12 h; after stirring, the step of centrifugation to eliminate bubbles in the solution is also included.

3. The preparation method according to claim 1, characterized in that: The computer-aided design software in step (2) includes CAD software; The temperature of the printing ink is 40-60°C; the printing parameter settings include: printing pressure is 0.06MPa-0.1MPa, printing speed is 8mm / s-16mm / s, printing spacing is 50μm-1000μm, platform temperature is 20-30°C, and needle diameter is 0.26mm-0.41mm.

4. The preparation method according to claim 1, characterized in that: The mass concentration of the calcium chloride solution in step (3) is 2%-5%, and the cross-linking time is 25-35 minutes; after cross-linking, the sodium alginate hydrogel is immersed in deionized water for 25-35 minutes, the residual calcium chloride solution is removed, and then vacuum freeze-dried for 36-48 hours.

5. The preparation method according to claim 1, characterized in that: The molecular weight of the polycaprolactone in step (4) is 200,000-400,000, and the heating temperature is 75-110°C.

6. The preparation method according to any one of claims 1 to 5, characterized in that: The parameter settings of the 3D electrospinning printer in step (4) include: printing temperature of 75°C-110°C, printing pressure of 5kPa-10kPa, printing speed of 10mm / s-100mm / s, acceleration of 100mm / s 2 -300mm / s 2 , the printing voltage is 1.4kV-2.8kV, the printing spacing is 10μm-100μm, the platform temperature is 20-30℃, and the needle diameter is 0.30mm-0.80mm.

7. A 3D customized medical dressing prepared by the preparation method according to any one of claims 1 to 6, characterized in that: The 3D customized medical dressing comprises a hydrophobic layer (1) and a hydrophilic layer (2).

8. The 3D customized medical dressing according to claim 7, characterized in that: The hydrophobic layer (1) has a thickness of 1 mm to 10 mm, and a contact angle of >100°; the hydrophilic layer (2) has a thickness of 1 mm to 100 mm, and a contact angle of <60°.

9. The 3D customized medical dressing according to claim 7, characterized in that: The pore size of the hydrophobic layer (1) is 10 μm-200 μm, and the pore size of the hydrophilic layer (2) is 1 μm-20 μm; the hydrophobic layer (1) is a polycaprolactone fiber membrane, and the hydrophilic layer (2) is a sodium alginate fiber membrane.